SOD2 and cancer: Some studies have associated low SOD2 activity with poor prognosis [15,20], whereas others have suggested that higher SOD2 activity is associated with worse outcomes in gastric [24], esophageal [26], breast [16,25], lung [27,28,29], cervical [17], and penile [30] cancers.